Skip to content

MSVision vs OMass Therapeutics

MSVision logo

MSVision

Your Independent European Mass Spectrometry Specialists - Specialists in Maintenance, Service and Native MS technology

39 employees · est. 2004 · Almere, The Netherlands

VS
OMass Therapeutics logo

OMass Therapeutics

OMass Therapeutics uses high-resolution mass spectrometry to discover drugs, targeting complicated medical needs, backed by Syncona and Oxford Science Enterprises

74 employees · est. 2016 · Oxford, United Kingdom

MSVision is the older company (2004 vs 2016); OMass Therapeutics is the larger of the two.

Side-by-Side Comparison

MSVision OMass Therapeutics
Founded
2004 older 2016
Headquarters
Almere, The Netherlands Oxford, United Kingdom
Employees
39 74 larger
Industry
Manufacturing Life Sciences, Pharmaceutical
Funding Stage
Not tracked yet Series B
Total Funding
Not tracked yet $128.00M
Funding Rounds
Not tracked yet 5
Services
Not tracked yet Proprietary biochemistry solutions, Native mass spectrometry integration, Custom chemistry applications
Target Customers
Not tracked yet Biotechnology researchers, Pharmaceutical companies, Academic institutions
Taxonomy
Mass SpectrometryService And MaintenanceNative MS TechnologyLC-MS/MS SupportBiopharma AnalysisBiologics +9 High-Resolution Mass SpectrometryDrug DiscoveryPharmaceuticalsStructural Mass SpectrometryProtein AssembliesMembrane Receptors +6
Website
msvision.com omass.com
MSVision logo

About MSVision

MSVision is a leading independent European mass spectrometry support company based in The Netherlands, with offices also in Germany and the UK. Established in 2004 by a team of experienced professionals from prominent mass spectrometry systems manufacturers, the company's goal is to provide unparall...

OMass Therapeutics logo

About OMass Therapeutics

OMass Therapeutics, founded in 2016 and headquartered in the United Kingdom, stands at the forefront of pharmaceutical innovation, emphasizing its prowess in Life Sciences and Pharmaceutical industries. Harnessing high-resolution mass spectrometry, the company aims to address complex medical needs b...

Also comparing in this category

Comparing more than these two?

Get MSVision, OMass Therapeutics and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does MSVision compare?

A PDF of MSVision and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Rival Readout

Comparing competitors? We do this properly.

10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.

Frequently Asked Questions

MSVision was founded in 2004, based in Almere, The Netherlands, with 39 employees. MSVision is a leading independent European mass spectrometry support company based in The Netherlands, with offices also in Germany and the UK. Established in 2004 by a team of experienced professiona. OMass Therapeutics was founded in 2016, based in Oxford, United Kingdom, with 74 employees. OMass Therapeutics, founded in 2016 and headquartered in the United Kingdom, stands at the forefront of pharmaceutical innovation, emphasizing its prowess in Life Sciences and Pharmaceutical industrie.
MSVision has raised no disclosed funding and OMass Therapeutics $128.00M. Latest stage: OMass Therapeutics Series B.

Compare MSVision with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at MSVision on 14 Sep 2024, and OMass Therapeutics on 11 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout